Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

22 May 2023 (13:00 - 13:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Stephen Greene

Duke Clinical Research Institute, Durham (United States of America)

7 More presentations in this session

Presentation thumbnail

Right ventricular function and coupling to the pulmonary circulation in heart failure with preserved ejection fraction: the PARAGON-HF trial

Doctor R. Inciardi (Brescia, IT)

Abstract Slides

Presentation thumbnail

Achieved heart rate of less than 70 beats per minute after ivabradine treatment is related to left ventricular reverse remodeling in idiopathic dilated cardiomyopathy

Ms J. Lee (Seoul, KR)

Abstract Slides

Presentation thumbnail

Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study

Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)

Abstract Slides

Presentation thumbnail

Cardiac reverse remodeling in real life, a therapeuthic objective.

Miss C. Otte Alba (Sevilla, ES)

Abstract Slides

Presentation thumbnail

Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin-system inhibitors: a difference-in-difference analysis of propensity score matched samples

Doctor S. Sforna (Perugia, IT)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - pathophysiology and mechanisms 1

The Event

Event poster

Heart Failure 2023

22 May 2023 13:00 CET

You may be interested in

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Congress Session

Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources